Discontinuation of Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia: a Review of the Biological Factors Associated with Treatment-Free Remission

PURPOSE OF REVIEW: Clinical factors alone do not enable us to differentiate which patients will maintain treatment-free remission (TFR) from those who are likely to relapse. Thus, patient-specific factors must also play a role. This review will update the reader on the most recent studies presenting...

Descripción completa

Detalles Bibliográficos
Autores principales: Stuckey, Ruth, López Rodríguez, Juan Francisco, Gómez-Casares, María Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Leukemia (A Aguayo, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930955/
https://www.ncbi.nlm.nih.gov/pubmed/35141859
http://dx.doi.org/10.1007/s11912-022-01228-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930955/
https://www.ncbi.nlm.nih.gov/pubmed/35141859
http://dx.doi.org/10.1007/s11912-022-01228-w

Ejemplares similares